- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
TMOS34
SAO
Week ended 07 Aug 2026
Weekly Investor Report
Thermo Fisher Scientific Inc. · Healthcare · Diagnostics & Research
Latest close
62.39 BRL
2.6%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is 14.4% above the Trend Line and sits at 63.7% of its 52-week range. The latest completed week returned 2.6%, after a 11.8% four-week move. The latest news-sentiment score is 59/100.
Setup score
58
out of 100
Latest Close
62.39 BRL
7 Aug 2026
1W Return
2.6%
latest completed week
4W Return
11.8%
short-term follow-through
12W Return
33.9%
quarterly tape
Trend Breadth
36.5%
19 of 52 weeks active
Volume Ratio
1.6x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Activity pressure is weak, so confirmation is not yet broad enough.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
2.6%
Latest completed week; four-week move 11.8%.
Indicator stack
20/80
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Recent
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
59/100
22 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is 14.4% above the Trend Line and sits at 63.7% of its 52-week range. The latest completed week returned 2.6%, after a 11.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.3212-week average 0.10
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.32Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 11.8% over four weeks, 33.9% over 12 weeks, and 20.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year19
Trend breadth36.5%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure1.22Latest activity-pressure read.
Pressure change100.5%Four-week change in activity pressure.
Leadership3.99Latest relative-leadership reading.
RS change137.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment59/100
Weighted news tone is positive across 22 relevant articles.
9 positive · 12 neutral · 1 negativePatient CapitalRecent
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-13.3%Distance below the 52-week high.
13-week volatility5.2%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher13 of 2613 weeks finished lower.
Best week+11.4%Week of 26 Jun.
Worst week-10.7%Week of 24 Apr.
Latest week+2.6%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains8
Flat weeks0
Modest losses9
Sharp losses4
Recent vol5.2%13-week weekly-return volatility.
Base vol4.8%52-week weekly-return volatility.
Up/down split27/25Count of positive and negative weeks in the 52-week window.
Average skew3.8% / -3.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorBR Healthcare
4-week rank9 / 82
Group average-0.7%
Trend breadth35.4%
Trend35.4%active weekly trend signals
MD65.9%positive activity pressure
RS46.3%positive relative leadership
Four-week leaders
IndustryBR Diagnostics & Research
4-week rank2 / 10
Group average4.4%
Trend breadth30.0%
Trend30.0%active weekly trend signals
MD90.0%positive activity pressure
RS50.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape50/100
Trend, activity pressure, participation, and risk combine to a 50/100 tape read.
Indicator analysis28/100Latest 12-week confirmation: trend 0/12, activity pressure 7/12, relative leadership 1/12.
Activity pressure 0.32; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalRecentActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
Recent buy signal in the last 8 weeks Sentiment59/100Weighted news tone is positive across 22 relevant articles.
Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 62.39 BRL | 2.6% | 54.56 BRL | 58.40 BRL | 1.22 | 3.99 | 23.4K | Off |
| 31 Jul 2026 | 60.79 BRL | 1.3% | 54.78 BRL | 58.36 BRL | 1.12 | -1.90 | 5.0K | Off |
| 24 Jul 2026 | 59.99 BRL | 5.4% | 55.00 BRL | 58.32 BRL | 1.05 | -1.33 | 8.3K | Off |
| 17 Jul 2026 | 56.89 BRL | 1.9% | 55.20 BRL | 58.29 BRL | 0.96 | -6.61 | 65.4K | Off |
| 10 Jul 2026 | 55.81 BRL | -2.1% | 55.46 BRL | 58.28 BRL | 0.61 | -10.74 | 29.7K | Off |
| 3 Jul 2026 | 57.02 BRL | 4.0% | 55.74 BRL | 58.26 BRL | 0.34 | -7.16 | 205 | Off |
| 26 Jun 2026 | 54.84 BRL | 11.4% | 55.99 BRL | 58.23 BRL | 0.00 | -10.25 | 1.5K | Off |
| 19 Jun 2026 | 49.21 BRL | -0.8% | 56.36 BRL | 58.21 BRL | -0.20 | -17.32 | 146 | Off |
| 12 Jun 2026 | 49.62 BRL | 5.0% | 56.91 BRL | 58.23 BRL | -0.47 | -18.06 | 748 | Off |
| 5 Jun 2026 | 47.27 BRL | -9.1% | 57.39 BRL | 58.25 BRL | -0.68 | -21.18 | 4.0K | Off |
| 29 May 2026 | 52.02 BRL | 10.4% | 57.92 BRL | 58.28 BRL | -0.74 | -15.92 | 2.2K | Off |
| 22 May 2026 | 47.11 BRL | 1.1% | 58.30 BRL | 58.29 BRL | -0.99 | -25.11 | 11.5K | Off |
| 15 May 2026 | 46.61 BRL | -1.9% | 58.88 BRL | 58.33 BRL | -1.06 | -26.61 | 37.3K | Off |
| 8 May 2026 | 47.50 BRL | -1.5% | 59.42 BRL | 58.39 BRL | -1.06 | -28.31 | 75.4K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.